Ioflupanum (123I)
Ioflupanum (123I) Uses, Dosage, Side Effects, Food Interaction and all others data.
Ioflupane (I-123) is a radiopharmaceutical used to image dopamine neurons and diagnose Parkinsonian syndromes.
iodine-123 labeled ioflupanebinds selectively to striatal presynaptic dopamine neurons by binding reversibly to presynaptic dopamine transporters.
Trade Name | Ioflupanum (123I) |
Generic | Ioflupane I-123 |
Ioflupane I-123 Other Names | 123I-FP-CIT, 123I-Ioflupane, Iodine ioflupane (123I), Ioflupane (123I), Ioflupane I 123, Ioflupane I(123), Ioflupano (123I), Ioflupanum (123I) |
Type | |
Formula | C18H23FINO2 |
Weight | Average: 427.291 Monoisotopic: 427.076880092 |
Groups | Approved |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Ioflupanum (123I) is a radiopharmaceutical used in single photon emission computed tomography (SPECT) brain imaging to help diagnose patients with suspected Parkinsonian syndromes.
Ioflupanum (123I) is a SPECT (single photon emission computerized tomography) agent used to distinguish between Parkinson’s syndrome tremors and essential tremor.
Ioflupanum (123I) is also used to associated treatment for these conditions: Parkinsonian Syndromes
How Ioflupanum (123I) works
Iodine-123 labeled ioflupane binds to presynaptic dopamine transporters. When Iodine-123 decays, a gammay ray is emmitted and detected through SPECT.
Food Interaction
- Take with or without food.
Volume of Distribution
Compared to the entire brain, about 30% of radioactivity is taken up by the striatum.
Elimination Route
Absorption is 100% because administered I.V.
Half Life
Half life is 13.2 hours.
Elimination Route
About 60% is excreted in the urine and 14% in the feces after 48 hours.
Innovators Monograph
You find simplified version here Ioflupanum (123I)